Inhibiting a protein involved in liver inflammation has the potential to reduce or stop fibrosis in patients with non-alcoholic steatohepatitis, trial finds
For the first time, researchers have shown a direct link between a blood vessel protein and cell growth arrest in the liver
The University of Birmingham-hosted BactiVac Network secures major funding to accelerate the development of bacterial vaccines.
Parth Narendran, Professor of Diabetes Medicine, has been awarded £860K funding towards type 1 diabetes general population screening of young people in Europe.
Professor Paul Moss has been appointed as the new Chair of the Medical Research Foundation’s Board of Trustees, with effect from October 2023.
Study received £2.8m of Department of Health and Social Care funding to find out if testing can identify which immunosuppressed people remain at greatest risk.
Ulcerative colitis assessment could be improved after new research shows that an AI model could predict flare-ups and complications after reading biopsies.
Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease.
University of Birmingham researchers have received a £1.8M grant by the NIHR EME Programme investigating BCG vaccine efficacy in reducing COPD exacerbations.
The IMPROVE clinical trial is testing whether vaccine timing can help clinically vulnerable people build antibodies
Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.